Charlie Albright

Charlie Albright

Company: Affinia Therapeutics

Job title: CSO


Re-engineering the Building Blocks of Gene Therapy: Improving Efficacy, Safety & Manufacturability of AAV With the ART Platform 9:30 am

Novel capsids with improved tissue targeting & immunogenic profile Novel promoters modulate transgene expression in specific cell typesRead more

day: Day One

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.